These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34992419)

  • 1. CTLA4-Mediated Immunosuppression in Glioblastoma is Associated with the Infiltration of Macrophages in the Tumor Microenvironment.
    Guan X; Wang Y; Sun Y; Zhang C; Ma S; Zhang D; Li D; Jia W
    J Inflamm Res; 2021; 14():7315-7329. PubMed ID: 34992419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.
    Wang Y; Liu Y; Zhang C; Zhang C; Guan X; Jia W
    Front Immunol; 2022; 13():1028937. PubMed ID: 36389681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
    Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
    Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
    [No Abstract]   [Full Text] [Related]  

  • 5. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
    Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
    Front Immunol; 2020; 11():585034. PubMed ID: 33193404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
    Long S; Li M; Liu J; Yang Y; Li G
    Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.
    Xiao Y; Yang K; Wang Z; Zhao M; Deng Y; Ji W; Zou Y; Qian C; Liu Y; Xiao H; Liu H
    Front Surg; 2021; 8():775194. PubMed ID: 35187044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma.
    Ren W; Jin W; Liang Z
    Front Neurol; 2022; 13():832944. PubMed ID: 35370869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of ferroptosis signature to evaluate the predict prognosis and immunotherapy in glioblastoma.
    Zhu X; Zhou Y; Ou Y; Cheng Z; Han D; Chu Z; Pan S
    Aging (Albany NY); 2021 Jul; 13(13):17655-17672. PubMed ID: 34244461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways.
    Jin X; Kang J; Lu Q; Guo SL; Liu M; Zhang Y; Cui C; Liu HL; Xu X; Yin J
    Front Genet; 2022; 13():1046008. PubMed ID: 36685974
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
    Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
    Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study.
    Wang Z; Gao L; Guo X; Wang Y; Wang Y; Ma W; Guo Y; Xing B
    Aging (Albany NY); 2020 Aug; 12(17):17038-17061. PubMed ID: 32857727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.